Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regio- and stereocontrolled total synthesis of benanomicin B.
Ohmori K, Tamiya M, Kitamura M, Kato H, Oorui M, Suzuki K. Ohmori K, et al. Among authors: tamiya m. Angew Chem Int Ed Engl. 2005 Jun 20;44(25):3871-4. doi: 10.1002/anie.200501210. Angew Chem Int Ed Engl. 2005. PMID: 15900522 No abstract available.
Total syntheses of amphidinolide H and G.
Fürstner A, Bouchez LC, Funel JA, Liepins V, Porée FH, Gilmour R, Beaufils F, Laurich D, Tamiya M. Fürstner A, et al. Among authors: tamiya m. Angew Chem Int Ed Engl. 2007;46(48):9265-70. doi: 10.1002/anie.200704024. Angew Chem Int Ed Engl. 2007. PMID: 17969211 No abstract available.
Identification of key gene signatures for predicting chemo-immunotherapy efficacy in extensive-stage small-cell lung cancer using machine learning.
Fujimoto D, Shibaki R, Kimura K, Haratani K, Tamiya M, Kijima T, Sato Y, Hata A, Yokoyama T, Taniguchi Y, Uchida J, Tanaka H, Furuya N, Miura S, Onishi MI, Sakata S, Miyauchi E, Yamamoto N, Koh Y, Akamatsu H. Fujimoto D, et al. Among authors: tamiya m. Lung Cancer. 2025 Jan;199:108079. doi: 10.1016/j.lungcan.2024.108079. Epub 2025 Jan 2. Lung Cancer. 2025. PMID: 39787635
Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy.
Kawachi H, Yamada T, Tamiya M, Negi Y, Kijima T, Goto Y, Nakao A, Shiotsu S, Tanimura K, Takeda T, Okada A, Harada T, Date K, Chihara Y, Hasegawa I, Tamiya N, Katayama Y, Nishioka N, Morimoto K, Iwasaku M, Tokuda S, Shimose T, Takayama K. Kawachi H, et al. Among authors: tamiya m. Oncoimmunology. 2025 Dec;14(1):2442116. doi: 10.1080/2162402X.2024.2442116. Epub 2024 Dec 16. Oncoimmunology. 2025. PMID: 39681395 Free PMC article.
Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study.
Sugisaka J, Fujimoto D, Tamiya M, Hata A, Matsumoto H, Yokoyama T, Taniguchi Y, Uchida J, Sato Y, Kijima T, Tanaka H, Furuya N, Masuda T, Sakata Y, Miyauchi E, Saito G, Miura S, Yamaguchi T, Daga H, Sakata S, Yamamoto N, Akamatsu H. Sugisaka J, et al. Among authors: tamiya m. Lung Cancer. 2025 Jan;199:108056. doi: 10.1016/j.lungcan.2024.108056. Epub 2024 Dec 9. Lung Cancer. 2025. PMID: 39674045
Lorlatinib overcomes alectinib-induced hemolytic anemia in an ALK fusion positive non-small-cell lung cancer patient with severe tumor-associated liver failure: A case report.
Kunimasa K, Miyazaki A, Tamiya M, Inoue T, Kawamura T, Tanaka T, Futamura S, Komuta K, Nagata S, Honma K, Ohkawa K, Nishino K. Kunimasa K, et al. Among authors: tamiya m. Thorac Cancer. 2024 Dec;15(36):2570-2574. doi: 10.1111/1759-7714.15487. Epub 2024 Nov 11. Thorac Cancer. 2024. PMID: 39527462 Free PMC article.
203 results